Am J Trop Med Hyg
- ALI GA, Goravey W
Disseminated Tuberculosis of the Axial Skeleton.
Am J Trop Med Hyg. 2024 Feb 20:tpmd230691. doi: 10.4269/ajtmh.23-0691.
Ann Intern Med
- ZIMILOVER A, Glatt AE
In nursing homes, universal decolonization vs. routine care reduced transfers to
hospital for infection.
Ann Intern Med. 2024;177:JC21.
Antimicrob Agents Chemother
- LI S-Y, Tyagi S, Soni H, Betoudji F, et al
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or
TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis.
Antimicrob Agents Chemother. 2024 Feb 20:e0156223. doi: 10.1128/aac.01562.
Biochemistry
- CAMPOMIZZI CS, Uttamrao PP, Stallone JJ, Rathinavelan T, et al
Asparagine-85 Stabilizes a Structural Active Site Water Network in CYP121A1 of
Mycobacterium tuberculosis.
Biochemistry. 2024 Feb 21. doi: 10.1021/acs.biochem.3c00555.
BMC Pediatr
- ALTASEB T, Lingerew M, Adane M
Prevalence of trachomatous inflammation-follicular and associated factors among
children aged 1-9 years in northeastern Ethiopia.
BMC Pediatr. 2024;24:128.
BMJ
- TANNE JH
Maternal syphilis rates tripled in the US between 2016 and 2022, data show.
BMJ. 2024;384:q416.
Cancer
- NOOKA AK, Rodriguez C, Mateos MV, Manier S, et al
Incidence, timing, and management of infections in patients receiving teclistamab
for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1
study.
Cancer. 2023 Nov 14. doi: 10.1002/cncr.35107.
Chest
- GODET C, Brun AL, Couturaud F, Laurent F, et al
CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary
Aspergillosis in Adults With Bronchial Asthma.
Chest. 2024 Feb 20:S0012-3692(24)00261-7. doi: 10.1016/j.chest.2024.
Clin Infect Dis
- PROSTY C, Hanula R, Katergi K, Longtin Y, et al
Clinical Outcomes and Management of NAAT-Positive/Toxin-Negative Clostridioides
difficile Infection: A Systematic Review and Meta-Analysis.
Clin Infect Dis. 2024;78:430-438.
- WALKER J, McCarty T, McGwin G, Ordaya EE, et al
Description of Cryptococcosis following SARS-CoV-2 infection: A disease survey
through the Mycosis Study Group Education and Research Consortium (MSG-19).
Clin Infect Dis. 2023 Sep 15:ciad551. doi: 10.1093.
- TUNKEL AR
Cefazolin for the Treatment of Central Nervous System Infections.
Clin Infect Dis. 2024;78:489-490.
- WANG M, Ge L, Chen L, Komarow L, et al
Clinical Outcomes and Bacterial Characteristics of Carbapenem-Resistant
Acinetobacter baumannii Among Patients from Different Global Regions.
Clin Infect Dis. 2023 Sep 20:ciad556. doi: 10.1093.
- HOWARD-ANDERSON J, Hamasaki T, Dai W, Collyar D, et al
Moving Beyond Mortality: Development and Application of a Desirability of Outcome
Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and
Ventilator-Associated Bacterial Pneumonia.
Clin Infect Dis. 2024;78:259-268.
- BAMPOE VD, Brown N, Deng L, Schiffer J, et al
Serologic Immunity to Tetanus in the United States, National Health and Nutrition
Examination Survey, 2015-2016.
Clin Infect Dis. 2024;78:470-475.
- RAO K, Zhao Q, Bell J, Krishnan J, et al
An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for
the Treatment of Clostridioides difficile Infection in Hospitalized Patients
Receiving Concomitant Antibiotics for Concurrent Infections.
Clin Infect Dis. 2024;78:277-282.
- PERI AM, O'Callaghan K, Rafiei N, Graves B, et al
Persistence of Detectable Pathogens by Culture-Independent Systems (T2 Magnetic
Resonance) in Patients With Bloodstream Infection: Prognostic Role and Possible
Clinical Implications.
Clin Infect Dis. 2024;78:283-291.
- TINGSGARD S, Bastrup Israelsen S, Ostergaard C, Benfield T, et al
Emulating a Target Trial of Shorter Compared to Longer Course of Antibiotic
Therapy for Gram-Negative Bacteremia.
Clin Infect Dis. 2024;78:292-300.
- KLINE MC, Kissler SM, Whittles LK, Barnett ML, et al
Spatiotemporal Trends in Group A Streptococcal Pharyngitis in the United States.
Clin Infect Dis. 2024 Feb 19:ciae083. doi: 10.1093.
- KARMARKAR EN, Fitzpatrick T, Himmelfarb ST, Chow EJ, et al
Cluster of non-toxigenic Corynebacterium diphtheriae infective endocarditis and
rising background C. diphtheriae cases-Seattle, Washington 2020-2023.
Clin Infect Dis. 2024 Feb 21:ciae094. doi: 10.1093.
Eur J Clin Microbiol Infect Dis
- CAO X, Guo T, Xin H, Du J, et al
Cost-effectiveness of latent tuberculosis infection testing and treatment with
6-week regimen among key population in rural communities in China: a decision
analysis study.
Eur J Clin Microbiol Infect Dis. 2024 Feb 22. doi: 10.1007/s10096-024-04777.
- DIEZ-VIDAL A, Gonzalez-Garcia ME, Marco-Clement I, Azores-Moreno J, et al
Recurrent bacteremia and endocarditis due to Staphylococcus capitis in a patient
with Bowen's disease: a case report.
Eur J Clin Microbiol Infect Dis. 2024 Feb 20. doi: 10.1007/s10096-024-04783.
- RANI V, Aye NK, Saksena R, Dabi KC, et al
Risk factors and outcome associated with the acquisition of MDR
linezolid-resistant Enterococcus faecium: a report from tertiary care centre.
Eur J Clin Microbiol Infect Dis. 2024 Feb 19. doi: 10.1007/s10096-024-04784.
J Antimicrob Chemother
- BRENCIANI A, Cinthi M, Coccitto SN, Massacci FR, et al
Global spread of the linezolid-resistant Enterococcus faecalis ST476 clonal
lineage carrying optrA.
J Antimicrob Chemother. 2024 Feb 15:dkae039. doi: 10.1093.
J Bacteriol
- ZHANG J-J, Raghunandanan S, Wang Q, Priya R, et al
BadR directly represses the expression of the glycerol utilization operon in the
Lyme disease pathogen.
J Bacteriol. 2024;206:e0034023.
J Infect Dis
- KAPIL P, Wang Y, Zimmerman L, Gaykema M, et al
"Repeated B. pertussis Infections are Required to Reprogram Acellular Pertussis
Vaccine-primed Host Responses in the Baboon Model".
J Infect Dis. 2023 Aug 11:jiad332. doi: 10.1093.
- SUNDERMANN AJ, Rangachar Srinivasa V, Mills EG, Griffith MP, et al
Two Artificial Tears Outbreak-Associated Cases of Extensively Drug-Resistant
Pseudomonas aeruginosa Detected Through Whole Genome Sequencing-Based
Surveillance.
J Infect Dis. 2024;229:517-521.
- BASU THAKUR P, Mrotz VJ, Maines TR, Belser JA, et al
Ferrets as a mammalian model to study influenza virus-bacteria interactions.
J Infect Dis. 2023 Sep 22:jiad408. doi: 10.1093.
- OH IS, Kim JH, Huh K, Jang SH, et al
Impact of National Public-Private Mix and Medical Expense Support Program for
Control Tuberculosis in South Korea: An Interrupted Time Series Analysis.
J Infect Dis. 2024 Feb 14:jiae059. doi: 10.1093.
- YAGLOM HD, Bhattarai R, Lemmer D, Rust L, et al
Large Clusters of Invasive emm49 Group A Streptococcus Identified within and
across Arizona Healthcare Facilities through Statewide Genomic Surveillance
System, 2019-2021.
J Infect Dis. 2024 Feb 19:jiae086. doi: 10.1093.
J Med Microbiol
- DA SILVA CR, Reboucas JDO, Cabral VPF, Rodrigues DS, et al
Promising activity of etomidate against mixed biofilms of fluconazole-resistant
Candida albicans and methicillin-resistant Staphylococcus aureus.
J Med Microbiol. 2024;73.
- MOHAMAD AZRANYI M, Aziz ZA, Ishak D, Mohd Nais NF, et al
Five-year species distribution and antimicrobial susceptibility of
non-tuberculous mycobacteria in Malaysia, 2018-2022.
J Med Microbiol. 2024;73.
- TAYLOR GM, White-Iribhogbe K, Cole G, Ashby D, et al
Bioarchaeological investigation of individuals with suspected multibacillary
leprosy from the mediaeval leprosarium of St Mary Magdalen, Winchester,
Hampshire, UK.
J Med Microbiol. 2024;73.
- AMBREETHA S, Zincke D, Balachandar D, Mathee K, et al
Genomic and metabolic versatility of Pseudomonas aeruginosa contributes to its
inter-kingdom transmission and survival.
J Med Microbiol. 2024;73.
Lancet
- KIMBALL AB, Ravichandran S
Secukinumab treatment of hidradenitis suppurativa: questions remain - Authors'
reply.
Lancet. 2024;403:617-618.
- ENDO M, Kami M
Secukinumab treatment of hidradenitis suppurativa: questions remain.
Lancet. 2024;403:617.
- MAUL JT, Kolios AGA, Thomsen SF, Ring HC, et al
Secukinumab treatment of hidradenitis suppurativa: questions remain.
Lancet. 2024;403:616-617.
- PETERS RPH, Klausner JD, Mazzola L, Mdingi MM, et al
Novel lateral flow assay for point-of-care detection of Neisseria gonorrhoeae
infection in syndromic management settings: a cross-sectional performance
evaluation.
Lancet. 2024;403:657-664.
- PAI NP, Dillon JR
A lateral flow assay for Neisseria gonorrhoeae: a step forward for an inexpensive
biomarker-based diagnosis of N gonorrhoeae at the point of care?
Lancet. 2024;403:594-595.
MMWR Morb Mortal Wkly Rep
- EDENS C, Clopper BR, DeVies J, Benitez A, et al
Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children
and Adolescents After the COVID-19 Pandemic, United States, 2018-2024.
MMWR Morb Mortal Wkly Rep. 2024;73:149-151.
- KUGELER KJ, Earley A, Mead PS, Hinckley AF, et al
Surveillance for Lyme Disease After Implementation of a Revised Case Definition -
United States, 2022.
MMWR Morb Mortal Wkly Rep. 2024;73:118-123.
Nat Med
- O'LEARY K
Digital intervention improves tuberculosis treatment outcomes.
Nat Med. 2024 Feb 19. doi: 10.1038/d41591-024-00009.
- DIACON AH, Barry CE 3rd, Carlton A, Chen RY, et al
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for
rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.
Nat Med. 2024 Feb 16. doi: 10.1038/s41591-024-02829.
PLoS Med
- SEMITALA FC, Kadota JL, Musinguzi A, Welishe F, et al
Comparison of 3 optimized delivery strategies for completion of
isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with
HIV in Uganda: A single-center randomized trial.
PLoS Med. 2024;21:e1004356.
PLoS Negl Trop Dis
- HOODA Y, Islam S, Kabiraj R, Rahman H, et al
Old tools, new applications: Use of environmental bacteriophages for typhoid
surveillance and evaluating vaccine impact.
PLoS Negl Trop Dis. 2024;18:e0011822.
PLoS One
- KIM D, Moon JS, Kim JE, Jang YJ, et al
Evaluation of purine-nucleoside degrading ability and in vivo uric acid lowering
of Streptococcus thermophilus IDCC 2201, a novel antiuricemia strain.
PLoS One. 2024;19:e0293378.
- CHAVAN VV, Dalal A, Nagaraja S, Thekkur P, et al
Correction: Ambulatory management of pre- and extensively drug resistant
tuberculosis patients with imipenem delivered through port-a-cath: A mixed
methods study on treatment outcomes and challenges.
PLoS One. 2024;19:e0299477.
- ADAMU Y, Puig-Asensio M, Dabo B, Schweizer ML, et al
Comparative effectiveness of daptomycin versus vancomycin among patients with
methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A
systematic literature review and meta-analysis.
PLoS One. 2024;19:e0293423.
- DAY AW, Kumamoto CA
Selection of ethanol tolerant strains of Candida albicans by repeated ethanol
exposure results in strains with reduced susceptibility to fluconazole.
PLoS One. 2024;19:e0298724.
- JONES J, Shi Q, Nath RR, Brito IL, et al
Keystone pathobionts associated with colorectal cancer promote oncogenic
reprograming.
PLoS One. 2024;19:e0297897.
- CANPOLAT ERKAN RE, Tekin R
Investigation of new inflammatory biomarkers in patients with brucella.
PLoS One. 2024;19:e0297550.
- KOIDE K, Uchitani Y, Yamaguchi T, Otsuka N, et al
Whole-genome comparison of two same-genotype macrolide-resistant Bordetella
pertussis isolates collected in Japan.
PLoS One. 2024;19:e0298147.
- MAFIZUR RM, Sangjin L, Chul PY
Prevalence of Salmonella spp. and Escherichia coli in the feces of free-roaming
wildlife throughout South Korea.
PLoS One. 2024;19:e0281006.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016